KalVista Pharmaceuticals ...

NASDAQ: KALV · Real-Time Price · USD
12.89
-0.06 (-0.46%)
At close: Aug 15, 2025, 3:59 PM
13.13
1.82%
After-hours: Aug 15, 2025, 07:39 PM EDT

KalVista Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Apr 30, 2025 Jan 31, 2025 Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Jan 31, 2024 Oct 31, 2023 Jul 31, 2023 Apr 30, 2023 Jan 31, 2023 Oct 31, 2022 Jul 31, 2022 Apr 30, 2022 Jan 31, 2022 Oct 31, 2021 Jul 31, 2021 Apr 30, 2021 Jan 31, 2021 Oct 31, 2020 Jul 31, 2020
Net Income
-52.23M -48.51M -42.27M -40.44M -44.65M -29.03M -27.65M -25.32M -26.3M -21.3M -22.26M -23.04M -24.11M -22.47M -19.65M -16.11M -14.96M -10.05M -10.43M -10.81M
Depreciation & Amortization
275K 229K 227K 224K 219K 207K 197K 193K 188K 199K 173K 158K 156K 149K 127K 132K 140K 136K 133K 128K
Stock-Based Compensation
-8.65M 2.61M 3M 3.04M 12.74M 2.71M 3.21M 3.25M 2.44M 2.33M 2.51M 2.64M 2.65M 2.78M 2.86M 2.79M 3.44M 1.24M 1.25M 1.19M
Other Working Capital
17.39M 1.66M 7.14M -2.56M -3.88M 3.02M 3.75M -108K -1.88M 11.69M -823K -2.68K -8.59M 5.04M -5.62M -4.84M -1.44M 2.94M 387K 6.3M
Other Non-Cash Items
1.45M 7.39M -814K -731K -28K 6.74M -19K -533K 32K -379K -790K 23K 1.65M 107K 24K 22K 89K 8K 9K 8K
Deferred Income Tax
n/a n/a n/a n/a n/a -7.17M 632K -108K -126K n/a n/a n/a n/a 1.26M 1.02M 790K 344K -239K 287K -434K
Change in Working Capital
18.79M 5.59M 213K -2.31M 16.61M -1.03M 3.81M -4.22M 1.13M 9.86M -226K -3.36M -7.13M 4.11M -3.93M -5.37M -103K 1.31M 798K 6.34M
Operating Cash Flow
-40.36M -32.68M -39.64M -40.22M -15.11M -27.57M -19.82M -26.73M -22.64M -9.29M -20.59M -22.74M -26.79M -14.06M -19.55M -17.73M -11.04M -7.59M -7.95M -3.59M
Capital Expenditures
350K -127K -202K -21K -416K -19K -205K -6K -69K -15K -192K -920K -86K -202K -356K -287K -33K -14K -13K -22K
Cash Acquisitions
434K n/a n/a n/a 105K n/a 203K -308K -936K 2.5K n/a n/a -57.86M n/a n/a 310K 147.65M n/a n/a -48K
Purchase of Investments
38.12M -6.56M -1K -983K -141.54M -18.15M -3.77M -25.77M -34.49M -53.66M n/a -10.1M -52.51M -32.72M -32.66M -19.04M -174.4M -7.47M -9.54M -9.81M
Sales Maturities Of Investments
21.18M 15.21M 47.91M 38.23M 15.48M 11.56M 32.53M 45.39M 28.35M 51.15M 20.29M 41.07M 65.03M 45.82M 50.66M 34.2M 7.95M 14.43M 15.92M 15.34M
Other Investing Acitivies
-63.08M -103K 743K -64K 294K -91K -203K 308K 936K -2.5K 20.29K 30.96K 57.86M 13.1K 18K -310K -147.65M 6.96K 6.38K 48K
Investing Cash Flow
-3.33M 8.52M 48.67M 37.16M -126.19M -6.7M 28.56M 19.61M -6.21M -2.52M 20.1M 30.04M 12.43M 12.9M 17.64M 14.88M -166.48M 6.95M 6.37M 5.51M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a -333 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
2.81M 95.23M n/a n/a 53.15M 284K 128K 204K n/a 57.81M 168K 168K 138K 772K 63K 608K 1.37M 55K 60K 46K
Financial Cash Flow
4.66M 151.77M 295K 3M 150.1M 284K 128K 204K -33K 57.81M 168K 168K 138K 772K 63K 608K 210.31M 1.7M 60K 46K
Net Cash Flow
-35.67M 126.36M 9.73M 59K 8.73M -34.61M 8.26M -6.83M -28.81M 46.46M 722K 7.13M -14.85M -914K -1.85M -2.25M 32.87M 1.55M -1.84M 2.23M
Free Cash Flow
-40.01M -32.81M -39.84M -40.24M -15.52M -27.59M -20.03M -26.74M -22.7M -9.3M -20.79M -23.66M -26.88M -14.27M -19.9M -18.02M -11.08M -7.6M -7.96M -3.61M